Exiqon operates in two business areas, Life Sciences and Diagnostics, which share:
One vision - pursue new scientific discoveries to improve healthcare
One focus - the promise of microRNA molecules as biological markers
One technology platform - our proprietary LNA™ (Locked Nucleic Acid) detection technology.
Exiqon Life Sciences is a leading supplier of products for microRNA research. Researchers around the world in academia, the biotechnology industry and the pharmaceutical industry are using our research products to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other diseases.
Exiqon Life Sciences markets its products globally on exiqon.com through a dedicated field sales force and via distributors.
Exiqon Services is part of Exiqon Life Sciences and focuses on collaborations with pharmaceutical companies that apply microRNA as biological markers in clinical research and clinical validation to reduce the time and cost of clinical trials, reduce adverse drug reactions and optimize therapies for patients’ individual needs.
Exiqon Diagnostics develops novel molecular diagnostic tests in collaboration with pharmaceutical and diagnostic companies. The unique value proposition of Exiqon Diagnostics is our ability to leverage the huge potential of microRNAs as a novel group of biomarkers with our proprietary LNA™ detection technology.
Exiqon is listed on the NASDAQ OMX in Copenhagen.
Specialties
Life Sciences and Diagnostics
Exiqon Activity on LinkedIn
-
Exiqon We have now announced the results of the 2012 Grant program. The quality of the applications was extremely high and it was very difficult to choose the recipients.
-
Exiqon Join us for a free webinar on microRNA discovery and biomarker development in clinical samples
-
Exiqon Exiqon can supply LNA™ technology for use in your clinical research – either as LNA™ oligos or as LNA™ phosphoramidites. See how LNA™ oligos can be used in vivo
